Director's Dealing • Nov 26, 2010
Director's Dealing
Open in ViewerOpens in native device viewer
Zealand Pharma A/S Attn.: CFO [Mats Blom] Email: $Fax:$
| Name of the person to make the re- | |
|---|---|
| Christian Hershind | |
| porting 1 | |
| The reason why reporting must be | |
| $m$ ade $^2$ | |
| Member of the Board of | |
| Issuer | Zealand Pharma A/S |
| ISIN code | |
| DK0060258549 | |
| Type 3 | |
| Shares | |
| Transaction 4 | |
| Subscription of shares in | |
| Trade date | |
| 23 Wovenber 2010 | |
| Market | |
| Nasdag onx Coperhagen A/S | |
| Number of traded securities | |
| 8,663 | |
| Market value in [DKK] | $18$ $0\times$ K |
<sup>1 Natural or legal person
<sup>2 Position or category of Related Parties, cf section 28a(4)(i) of the Danish Securities Trading etc Act (spouse or co-habitee), (ii) (underage children), (iii) (relatives) and legal persons $((iv)(a) - (d))$
<sup>3 For example shares, share options, warrants
<sup>4 For example purchase or sale
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.